An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

被引:0
|
作者
Lang Wu
Yaohua Yang
Xingyi Guo
Xiao-Ou Shu
Qiuyin Cai
Xiang Shu
Bingshan Li
Ran Tao
Chong Wu
Jason B. Nikas
Yanfa Sun
Jingjing Zhu
Monique J. Roobol
Graham G. Giles
Hermann Brenner
Esther M. John
Judith Clements
Eli Marie Grindedal
Jong Y. Park
Janet L. Stanford
Zsofia Kote-Jarai
Christopher A. Haiman
Rosalind A. Eeles
Wei Zheng
Jirong Long
机构
[1] University of Hawaii at Manoa,Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center
[2] Vanderbilt University Medical Center,Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt
[3] Vanderbilt University,Ingram Cancer Center
[4] Vanderbilt University Medical Center,Department of Molecular Physiology & Biophysics
[5] Vanderbilt University Medical Center,Vanderbilt Genetics Institute
[6] Florida State University,Department of Biostatistics
[7] Genomix Inc,Department of Statistics
[8] Longyan University,Research & Development
[9] Erasmus University Medical Center,College of Life Science
[10] University of Melbourne,Department of Urology
[11] Cancer Council Victoria,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health
[12] German Cancer Research Center (DKFZ),Cancer Epidemiology & Intelligence Division
[13] German Cancer Research Center (DKFZ),Division of Clinical Epidemiology and Aging Research
[14] German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT),German Cancer Consortium (DKTK)
[15] Stanford University School of Medicine,Division of Preventive Oncology
[16] Queensland University of Technology,Department of Medicine (Oncology) and Stanford Cancer Institute
[17] Translational Research Institute,Australian Prostate Cancer Research Centre
[18] Oslo University Hospital,QLD, Institute of Health and Biomedical Innovation and School of Biomedical Science
[19] Moffitt Cancer Center,Department of Medical Genetics
[20] Fred Hutchinson Cancer Research Center,Department of Cancer Epidemiology
[21] University of Washington,Division of Public Health Sciences
[22] The Institute of Cancer Research,Department of Epidemiology, School of Public Health
[23] and The Royal Marsden NHS Foundation Trust,Division of Genetics and Epidemiology
[24] University of Southern California,Department of Preventive Medicine
[25] Case Western Reserve University,Department of Population and Quantitative Health Sciences
[26] Seidman Cancer Center,Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge
[27] University Hospitals,Division of Population Health, Health Services Research and Primary Care
[28] Strangeways Research Laboratory,Warwick Medical School
[29] University of Cambridge,Division of Cancer Epidemiology and Genetics
[30] Department of Clinical Neurosciences,Department of Medical Epidemiology and Biostatistics
[31] University of Manchester,Epidemiology Research Program
[32] University of Warwick,SWOG Statistical Center
[33] National Cancer Institute,Institute of Health and Biomedical Innovation and School of Biomedical Sciences
[34] NIH,Centre for Cancer Genetic Epidemiology, Department of Oncology
[35] Karolinska Institute,Tyks Microbiology and Genetics, Department of Medical Genetics
[36] American Cancer Society,Division of Nutritional Epidemiology, Institute of Environmental Medicine
[37] Fred Hutchinson Cancer Research Center,Department of Surgical Sciences
[38] Queensland University of Technology,Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related Research, Manchester NIHR Biomedical Research Centre
[39] University College London,Department of Epidemiology
[40] Department of Applied Health Research,Department of Molecular Medicine
[41] University of Cambridge,Department of Clinical Medicine
[42] Strangeways Laboratory,University of Cambridge, Department of Oncology
[43] Institute of Biomedicine,Cancer Research UK Cambridge Research Institute
[44] Kiinamyllynkatu 10,Nuffield Department of Surgical Sciences, Faculty of Medical Science
[45] FI-20014 University of Turku,School of Social and Community Medicine
[46] Turku University Hospital,Department of Surgical Oncology
[47] Karolinska Institutet,Department of Radiation Oncology
[48] Uppsala University,Department of Genetics and Genomic Sciences
[49] The Christie Hospital NHS Foundation Trust,Centre for Molecular Oncology, Barts Cancer Institute
[50] Harvard School of Pubic Health,Division of Urologic Surgery
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
It remains elusive whether some of the associations identified in genome-wide association studies of prostate cancer (PrCa) may be due to regulatory effects of genetic variants on CpG sites, which may further influence expression of PrCa target genes. To search for CpG sites associated with PrCa risk, here we establish genetic models to predict methylation (N = 1,595) and conduct association analyses with PrCa risk (79,194 cases and 61,112 controls). We identify 759 CpG sites showing an association, including 15 located at novel loci. Among those 759 CpG sites, methylation of 42 is associated with expression of 28 adjacent genes. Among 22 genes, 18 show an association with PrCa risk. Overall, 25 CpG sites show consistent association directions for the methylation-gene expression-PrCa pathway. We identify DNA methylation biomarkers associated with PrCa, and our findings suggest that specific CpG sites may influence PrCa via regulating expression of candidate PrCa target genes.
引用
收藏
相关论文
共 50 条
  • [31] A pan-cancer integrative pathway analysis of multi-omics data
    Henry Linder
    Yuping Zhang
    Quantitative Biology, 2020, 8 (02) : 130 - 142
  • [32] A pan-cancer integrative pathway analysis of multi-omics data
    Linder, Henry
    Zhang, Yuping
    QUANTITATIVE BIOLOGY, 2020, 8 (02) : 130 - 142
  • [33] Integrating muti-omics data to identify tissue-specific DNA methylation biomarkers for cancer risk
    Yang, Yaohua
    Chen, Yaxin
    Xu, Shuai
    Guo, Xingyi
    Jia, Guochong
    Ping, Jie
    Shu, Xiang
    Zhao, Tianying
    Yuan, Fangcheng
    Wang, Gang
    Xie, Yufang
    Ci, Hang
    Liu, Hongmo
    Qi, Yawen
    Liu, Yongjun
    Liu, Dan
    Li, Weimin
    Ye, Fei
    Shu, Xiao-Ou
    Zheng, Wei
    Li, Li
    Cai, Qiuyin
    Long, Jirong
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [34] DNA methylation exploration for ARDS: a multi-omics and multi-microarray interrelated analysis
    Zhang, Shi
    Wu, Zongsheng
    Xie, Jianfeng
    Yang, Yi
    Wang, Lei
    Qiu, Haibo
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [35] DNA methylation exploration for ARDS: a multi-omics and multi-microarray interrelated analysis
    Shi Zhang
    Zongsheng Wu
    Jianfeng Xie
    Yi Yang
    Lei Wang
    Haibo Qiu
    Journal of Translational Medicine, 17
  • [36] A multi-omics signature for patients' risk classification in prostate cancer.
    Xu, Zhuoran
    Benedetti, Elisa
    Carelli, Ryan
    Rosenthal, Jacob
    Pakula, Hubert
    Omar, Mohamed
    Umeton, Renato
    Brundage, David
    Krumsiek, Jan
    Loda, Massimo
    Marchionni, Luigi
    CANCER RESEARCH, 2022, 82 (12)
  • [37] DNA methylation biomarkers and myopia: a multi-omics study integrating GWAS, mQTL and eQTL data
    Dong, Xing-Xuan
    Chen, Dong-Ling
    Chen, Hui-Min
    Li, Dan-Lin
    Hu, Dan-Ning
    Lanca, Carla
    Grzybowski, Andrzej
    Pan, Chen-Wei
    CLINICAL EPIGENETICS, 2024, 16 (01)
  • [38] Integrative analysis of multi-omics data to identify three immune-related genes in the formation and progression of intracranial aneurysms
    Li, Shifu
    Zhang, Qian
    Huang, Zheng
    Chen, Fenghua
    INFLAMMATION RESEARCH, 2023, 72 (05) : 1001 - 1019
  • [39] Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma
    Alivand, Mohammad Reza
    Najafi, Sajad
    Esmaeili, Sajjad
    Rahmanpour, Dara
    Zhaleh, Hossein
    Rahmati, Yazdan
    CANCER GENETICS, 2021, 258 : 135 - 150
  • [40] Integrative analysis of multi-omics data to identify three immune-related genes in the formation and progression of intracranial aneurysms
    Shifu Li
    Qian Zhang
    Zheng Huang
    Fenghua Chen
    Inflammation Research, 2023, 72 : 1001 - 1019